The inclusion of platinum-resistant ovarian cancer as an expansion cohort in the study was based on the literature suggesting that platinum resistance may promote a mesenchymal phenotype, which is associated with elevated AXL expression in tumors (25). The gene discussed is AXL; the disease is ovarian cancer.